Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants

Abstract

A population pharmacokinetic model of cefepime in neonates and young infants was established. According to simulation results based on the developmental pharmacokinetics-pharmacodynamics, different dosage regimens should be given depending on pathogens and the postmenstrual age.